Form 4: Protara Therapeutics Executive's Stock Vesting Tax Withholding
Insider Transaction Report
Protara Therapeutics' Chief Scientific Operations Officer, Jacqueline Zummo, reported the withholding of 3,724 shares of common stock to cover tax obligations related to a restricted stock unit award vesting.
Summary
- Jacqueline Zummo, Chief Scientific Operations Officer of Protara Therapeutics, Inc. (TARA), reported a transaction on January 26, 2026.
- The transaction involved the disposition of 3,724 shares of common stock.
- These shares were withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit (RSU) Award.
- The shares were disposed of at a price of $6.67 per share.
- Following this transaction, Jacqueline Zummo beneficially owns 118,559 shares of Protara Therapeutics common stock.
- The original Restricted Stock Unit Award was granted to the Reporting Person on January 24, 2025.
Sentiment
Score: 5
Explanation: The filing reports a routine, non-discretionary transaction related to tax withholding upon RSU vesting, which is neutral in sentiment and does not indicate positive or negative company performance or outlook.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, specifically a tax withholding event related to equity compensation. It does not provide information that directly relates to broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in management's discretionary view of the company's prospects.
- Employees: This transaction is typical for equity compensation plans and does not indicate broader changes in employee compensation or benefits.
Key Dates
| Date | Description |
|---|---|
| January 24, 2025 | Date of grant for the Restricted Stock Unit Award to the Reporting Person. |
| January 26, 2026 | Transaction date for the disposition of shares due to tax withholding upon RSU vesting. |
| January 27, 2026 | Date the Form 4 was signed by Jacqueline Zummo. |
Keywords
Protara Therapeutics, TARA, Jacqueline Zummo, Form 4, Insider Transaction, Restricted Stock Unit, RSU Vesting, Tax Withholding, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.